Esmaili-Hesari Ramezan-Ali, Homai-Shandiz Fatemeh, Motevallian Abbas, Madjd Zahra, Solaymani-Dodaran Masoud, Asadi-Lari Mohsen
Department of Epidemiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Int J Prev Med. 2012 Nov;3(11):783-90.
Oesophagogastric (OG) cancer as a globally common and deadly malignancy, which is widely spread in Northeast Iran, has an extensive impact on health-related quality of life (HRQL). Demographic and histopathologic changes have been apparent in oesophagogastric cancer, therefore. HRQL could be used, as an outcome, to assess and determine the efficacy and impact of cancer care.
A consecutive sample of upper-gastrointestinal cancer patients admitted to the main oncology/ radiotherapy departments in the North-East of Iran were recruited into the study. All participants completed the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 and QLQ-OG25questionnaires in a face to face interview.
Of the total 275 patients participated in the study, 54% had oesophageal, 34% stomach and 12% OG junction cancers. About 73.1% had TNM (tumour, node, metastasis) staging; of which 69% were in stage III and IV. The most common type of cancer in oesophagus was Squamous Cell Carcinoma (SCC) (95.3%) in lower third, Adenocarcinoma in stomach (97.8%) and in the OG junction (93.8%). Patients with stomach or OG junction tended more to present in higher stages (P < 0.001). Unlike QLQ-C30, the EORTC QLQ-OG25 was able to differ patients significantly in anxiety scale (P = 0.01), body image, chocking and weight loss (P < 0.05). Those who had self care ability had better quality of life scores (P < 0.001) in more scales and items.
SCC is predominant type of upper GI cancer in Khorasan provinces similar to the high risk area in Northern Iran. The specific health-related quality of life tool (EORTC QLQ-OG25) was able to distinguish most of the symptoms in patients with upper GI cancer.
食管胃癌作为一种全球常见且致命的恶性肿瘤,在伊朗东北部广泛传播,对健康相关生活质量(HRQL)有广泛影响。因此,食管胃癌在人口统计学和组织病理学方面都有明显变化。HRQL可作为一项指标,用于评估和确定癌症治疗的疗效及影响。
选取伊朗东北部主要肿瘤学/放射治疗科收治的上消化道癌症患者连续样本纳入研究。所有参与者在面对面访谈中完成了欧洲癌症研究与治疗组织(EORTC)的QLQ-C30和QLQ-OG25问卷。
参与研究的275例患者中,54%患有食管癌,34%患有胃癌,12%患有食管胃交界癌。约73.1%进行了TNM(肿瘤、淋巴结、转移)分期;其中69%处于III期和IV期。食管癌最常见的类型是下三分之一段的鳞状细胞癌(SCC)(95.3%),胃癌为腺癌(97.8%),食管胃交界癌为腺癌(93.8%)。胃癌或食管胃交界癌患者更倾向于处于较高分期(P < 0.001)。与QLQ-C30不同,EORTC QLQ-OG25在焦虑量表(P = 0.01)、身体形象、哽咽和体重减轻方面能显著区分患者(P < 0.05)。具有自我护理能力的患者在更多量表和项目上的生活质量得分更高(P < 0.001)。
与伊朗北部的高风险地区类似,霍拉桑省上消化道癌症的主要类型是SCC。特定的健康相关生活质量工具(EORTC QLQ-OG25)能够区分上消化道癌症患者的大多数症状。